TC2N and pheochromocytoma: TC2N transcription was significantly lower in pheochromocytoma and paraganglioma (PCPG), skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA) and uterine carcinosarcoma (UCS) (Figure 1A, Figure 1C).